Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-01-15FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a fluoxetine generic product manufactured by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Religiously Integrated Cognitive Behavioral Therapy [NA]
The clinical trial evaluating Religiously Integrated Cognitive Behavioral Therapy for panic disorder and generalized anxiety disorder has co…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity [NA]
This clinical trial update notes ongoing recruitment for a study validating an autonomous internet-based delivery of empirically supported c…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Neurofeedback Enhanced Cognitive Reappraisal Training [NA]
Clinical trial of Neurofeedback Enhanced Cognitive Reappraisal Training for anxiety-related disorders completed; results have been posted.
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Efficacy and Safety of HB-1 for Panic Disorder [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of HB-1 for panic disorder is currently recruiting, sponsored by HB BioTech, LLC…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders
The University of Toronto is conducting a clinical study to investigate pathogenic gut microbiota patterns in anxiety, panic disorder, mood …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups
This clinical trial aims to subclass mental health conditions within diabetes using digital twins to enable precision mental health tracking…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Guided and Traditional Cognitive Behavioral Therapy Protocol for Resistant Panic [NA]
A completed clinical trial from Universidade Federal do Rio de Janeiro evaluating guided versus traditional cognitive behavioral therapy pro…
-
FDA approval · 2025-11-20FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sertraline hydrochloride manufactured by Aurobindo Pharma Limited. This approval covers a generi…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Comparing Individual Therapies for Veterans With Depression, PTSD, and Panic Disorder [NA]
VA-sponsored clinical trial comparing individual therapies for veterans with major depressive disorder, posttraumatic stress disorder, and p…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment [NA]
An update on a completed clinical trial focused on building an outcomes assessment infrastructure for evaluating anxiety treatments. Sponsor…
-
FDA approval · 2025-09-26FDA Approved: FLUOXETINE — Supplemental Application (NIVAGEN PHARMACEUTICALS, INC.)
FDA approves a supplemental application for fluoxetine hydrochloride from NIVAGEN Pharmaceuticals, enabling the marketing of a generic fluox…
-
FDA approval · 2025-09-24FDA Approved: PAROXETINE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals Inc. Paroxetine Original Application for a generic paroxetine product.
-
FDA approval · 2025-09-17FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Epic Pharma, LLC under an ANDA.
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Differential Effects of in Vivo and Virtual Exposure Therapy in Agoraphobia [NA]
This trial from Johannes Gutenberg University Mainz compares in vivo versus virtual exposure therapy for agoraphobia, panic disorder, and so…
-
FDA approval · 2025-09-02FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for a generic venlafaxine hydrochloride product.
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety [NA]
A University of Texas at Austin trial is actively recruiting to evaluate whether respiratory training can treat transdiagnostic pathological…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD [NA]
A clinical trial evaluating internet-based cognitive-behavioral therapy versus parent-coached CBT for obsessive-compulsive disorder and vari…
-
FDA approval · 2025-07-11FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for fluoxetine hydrochloride submitted by Quallent Pharmaceuticals Health LLC, indicating an update …
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Preoperative Pregabalin vs Gabapentin in Elderly Undergoing Surgry,Controlled Trial [NA]
A controlled preoperative trial compares pregabalin to gabapentin in elderly surgical patients, focusing on anxiety-related conditions such …
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method [NA]
Georgetown University is conducting a clinical trial to evaluate mindful self-compassion for anxiety and depression and to compare delivery …
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Mindful Self-Compassion for Anxiety Disorders and Depression [NA]
Georgetown University is conducting a clinical trial to evaluate mindful self-compassion for anxiety disorders and major depressive disorder…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4 [NA]
Phase 4 clinical trial evaluating neurofeedback-enhanced cognitive reappraisal training for anxiety-related disorders is currently recruitin…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Effects and Cost-effectiveness of e-Meistring - a Guided Internet-delivered Psychological Treatment
This update describes a clinical trial evaluating the effects and cost-effectiveness of e-Meistring, a guided internet-delivered psychologic…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders [NA]
A recruiting clinical trial evaluating SYMPTOMS-JIT as an in vivo exposure therapy approach for anxiety disorders, including specific phobia…